慢性阻塞性肺疾病急性加重期的早期规范化治疗效果分析

Analysis of the Effectiveness of Early Standardized Treatment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的:探讨慢阻肺急性加重期患者应用早期规范化治疗的临床疗效、安全性。方法:选取蚌埠医科大学第二附属医院2022年1月到2023年12月收治的慢阻肺急性加重期患者62例作为案例,以随机数表法进行分组,每组31例。常规组采取常规对症治疗,实验组采用早期规范化治疗。分析探讨患者治疗有效率、肺功能、血气分析指标、不良反应发生情况。结果:实验组治疗有效率、肺功能、血气分析指标均明显优于常规组,P<0.05。实验组不良反应发生率明显低于常规组,P<0.05。结论:慢阻肺急性加重期采用早期规范化治疗效果显著,可以改善肺功能,值得推广。

Objective:To explore the clinical efficacy and safety of early standardized treatment in patients with acute exacerbation of chronic obstructive pulmonary disease.Methods:62 patients with acute exacerbation of COPD admitted to the Second Affiliated Hospital of Bengbu Medical University from January 2022 to December 2023 were selected as cases and divided into groups by the random number table method,with 31 cases in each group.The conventional group received conventional symptomatic treatment,and the experimental group received early standardized treatment.The patients’treatment effectiveness,lung function,blood gas analysis indicators,and occurrence of adverse reactions were analyzed and discussed.Results:The treatment response rate,lung function and blood gas analysis indexes in the experimental group were significantly better than those in the conventional group,P<0.05.T he i ncidence of a dverse r eactions i n t he experimental g roup was significantly lower t han t hat i n t he conventional group,P<0.05.Conclusion:Early standardized treatment in acute exacerbation of COPD has significant effects and can improve lung function,which is worthy of promotion.